Health Care [ 6/12 ] | Biotechnology [ 45/74 ]
NASDAQ | Common Stock
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies.
The company was incorporated in 2007 and is headquartered in Purchase, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 8, 24 | -0.18 Decreased by -12.50% | -0.23 Increased by +21.74% |
| May 7, 24 | -0.27 Decreased by -28.57% | -0.25 Decreased by -8.00% |
| Mar 26, 24 | -0.27 Decreased by -35.00% | -0.34 Increased by +20.59% |
| Nov 2, 23 | -0.22 Increased by +24.14% | -0.24 Increased by +8.33% |
| Aug 8, 23 | -0.16 Increased by +36.00% | -0.19 Increased by +15.79% |
| May 4, 23 | -0.21 Decreased by -23.53% | -0.18 Decreased by -16.67% |
| Mar 23, 23 | -0.20 Increased by +98.30% | -0.22 Increased by +9.09% |
| Nov 14, 22 | -0.29 Increased by +96.43% | -0.38 Increased by +23.68% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 0.00 Decreased by N/A% | -7.04 M Decreased by -48.98% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -9.15 M Decreased by -170.66% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 372.00 K Increased by +N/A% | -8.14 M Decreased by -174.20% | Decreased by -2.19 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -6.75 M Decreased by -979.84% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.73 M Increased by +17.84% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -3.38 M Increased by +11.91% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | 10.97 M Increased by +249.50% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -625.00 K Increased by +79.90% | Decreased by N/A% Decreased by N/A% |